Search research articles
Contact Us
Filters
Showing results (581-590 of 644) with videos related to
Page
of 65
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study
S O'Reilly, G F Fleming, S D Barker, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)
|
September 1, 1993
[An epidemiological study of tuberculosis in the health area of Santiago de Compostela during the years 1989, 1990 and 1991]
M Salgueiro Rodríguez, C Zamarrón Sanz, P Alvarez-Calderón Prat, et al.
BMC Plant Biology
|
July 10, 2020
Unveiling the genetic basis of Sclerotinia head rot resistance in sunflower
C V Filippi, J E Zubrzycki, J A Di Rienzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer
Kellie Matthews, Patricia E Noker, Baohong Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2002
A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancer
Ronald D Alvarez, Warner K Huh, M B Khazaeli, et al.
Plant Disease
|
January 25, 2019
Phenotyping Sunflower Genetic Resources for Sclerotinia Head Rot Response: Assessing Variability for Disease Resistance Breeding
C V Filippi, J E Zubrzycki, J A Di Rienzo, et al.
Gene Therapy
|
March 19, 2004
Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter
Z B Zhu, S K Makhija, B Lu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 4, 2009
Effect of TRA-8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer model
Peter J Frederick, James E Kendrick, J Michael Straughn, et al.
Cancer Letters
|
August 19, 2018
FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer
Kelly M Kreitzburg, Samuel C Fehling, Charles N Landen, et al.
Gynecologic Oncology
|
December 17, 2003
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy
Warner K Huh, Matthew Powell, Charles A Leath, et al.
Page
of 65
Search research articles
Search
Showing results (581-590 of 644) with videos related to
Sort By:
Page
of 65
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study
S O'Reilly, G F Fleming, S D Barker, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)
|
September 1, 1993
[An epidemiological study of tuberculosis in the health area of Santiago de Compostela during the years 1989, 1990 and 1991]
M Salgueiro Rodríguez, C Zamarrón Sanz, P Alvarez-Calderón Prat, et al.
BMC Plant Biology
|
July 10, 2020
Unveiling the genetic basis of Sclerotinia head rot resistance in sunflower
C V Filippi, J E Zubrzycki, J A Di Rienzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer
Kellie Matthews, Patricia E Noker, Baohong Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2002
A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancer
Ronald D Alvarez, Warner K Huh, M B Khazaeli, et al.
Plant Disease
|
January 25, 2019
Phenotyping Sunflower Genetic Resources for Sclerotinia Head Rot Response: Assessing Variability for Disease Resistance Breeding
C V Filippi, J E Zubrzycki, J A Di Rienzo, et al.
Gene Therapy
|
March 19, 2004
Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter
Z B Zhu, S K Makhija, B Lu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 4, 2009
Effect of TRA-8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer model
Peter J Frederick, James E Kendrick, J Michael Straughn, et al.
Cancer Letters
|
August 19, 2018
FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer
Kelly M Kreitzburg, Samuel C Fehling, Charles N Landen, et al.
Gynecologic Oncology
|
December 17, 2003
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy
Warner K Huh, Matthew Powell, Charles A Leath, et al.
Page
of 65